Notably, Gal-3 has also been suggested to be a marker of coronavirus disease 2019 (COVID-19) severity, and the inhibition of Gal-3 may reduce inflammation and fibrosis in patients with COVID-19 [40, 41]. Here, LGALS3 is linked to COVID-19.